Forbes August 20, 2024
Arianna Johnson

Topline

New study results found weight loss and diabetes drugs Zepbound and Mounjaro may significantly cut the risk of diabetes in people with prediabetes and obesity, adding to the growing list of diseases researchers have found the drugs can prevent.

Key Facts

Big Number

98 million. That’s about how many Americans have prediabetes, totaling around one in three adults in the U.S., according to data from the Centers for Disease Control and Prevention.

What Is Prediabetes?

People with prediabetes have higher than normal blood sugar levels, but they aren’t high enough to be considered type 2 diabetes. It’s caused by insulin resistance—the same thing that causes type 2 diabetes—which can happen because of genetics, excess body fat, a diet high...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Patient / Consumer, Pharma / Biotech, Provider, Survey / Study, Trends
Pharma Pulse 11/25/24: Deepening Patient Relationships, Menopause May Increase Risk of Asthma & more
Axolotl Biosciences Brings Biotech to the Forefront at Formnext 2024
Innovative approach maps gene activity in the living human brain
Trump tariffs could drive up generic drug costs: 5 takeaways
Answer ALS, Cedars-Sinai Collaboration, Single-Cell Protein Profiling, ChapsVision Acquires Sinequa, More

Share This Article